A clinical trial is currently enrolling at sites to test an investigational medication, known as Valnivudine™, for shingles and post-herpetic neuralgia (PHN) pain. “Investigational” means it’s not yet approved by the FDA or available for use by the public.
In order to participate in the study, patients should recognize the early symptoms of shingles and contact a study site within 5 days of the shingles rash appearing.
If you volunteer and meet the study requirements, your participation may last up to approximately 120 days. During that time you’ll make up to 12 visits to your local clinical trial site office. If for some reason you need to leave the study, you may do so at any time, for any reason.
Health insurance and referrals aren’t required to participate. All study medication as well as study-related procedures will be provided at no cost.
What are the Next Steps for Participation?
The site will give you information about the Valnivudine™ study and will help determine if you might qualify.
At the doctor’s office, our study staff will explain the study procedures and its possible benefits and risks. They’ll also ask some health questions and may refer you for further medical evaluation to make sure you meet the requirements for the study. To join our study, you must read and sign a document called an informed consent to show that you understand the study and what’s required of you.
If eligible, you’ll enter the study for up to 120 days, and make about 12 visits to our offices during that time. The staff will work with you to find convenient times for these visits. If for some reason you need to leave the study, you may do so at any time, for any reason.
Remember to ask questions! Your study doctor will explain the benefits and risks of being in this research study. Please use this opportunity to ask questions. You may also talk to your family doctor to help you decide if this research study is right for you.
What is a Clinical Trial?
A clinical research study is a research project done with human volunteers to learn more about new investigational drugs and treatments. Some volunteers are interested in access to investigational drugs or treatments. Others volunteer to help advance science. Whatever your reason is for participating, we’ll monitor your health and protect your privacy.
To learn more about clinical trials, visit: www.clinicaltrials.gov
Shingles is on the rise and more potent drugs are needed. The Valnivudine clinical trial will help the medical community learn more about how to best treat this disease so everyone can stay as healthy as possible.Dr. Stephen K. Tyring, M.D., Ph.D., Dermatologist and Virologist